Synthetic route to scopolamine and/or atropine

US11739084B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11739084-B2
Application numberUS-202117450254-A
CountryUS
Kind codeB2
Filing dateOct 7, 2021
Priority dateOct 7, 2021
Publication dateAug 29, 2023
Grant dateAug 29, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A synthetic route to scopolamine and/or atropine. In such context, the present invention identifies a method for preparing 6,7-dehydro atropine, which can be converted into either scopolamine and/or atropine, along with a method for converting a protected pyrrole into a tetrachlorobicylic compound, such as benzyl 3-oxo-8-azabicyclo[3.2.1]oct-6-ene-8-carboxylate.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for preparing 6,7-dehydro atropine comprising: (a) providing a protected pyrrole having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (b) reacting the protected pyrrole with pentachloroacetone and forming a first tetrachloro-bicyclic compound having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (c) carrying out a reductive dechlorination of said first tetrachloro-bicyclic compound and forming a second bicyclic compound having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (d) carrying out a reductive methylation of the second bicyclic compound formed in step (c) and forming or 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3-ol having the following formula: (e) converting 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3-ol into 6,7-dehydro tropene tosylate having the following formula: wherein − OTs is reference to − OSO 2 —Ar—CH 3 ; and (f) converting 6,7-dehydro tropene tosylate into 6,7-dehydro atropine having the following formula: 2. The method of claim 1 wherein 6,7-dehydro atropine is converted by oxidation into scopolamine having the following formula: 3. The method of claim 2 wherein said oxidation of 6,7-dehydro atropine occurs in the presence of manganese sulfate, hydrogen peroxide and sodium bicarbonate. 4. The method of claim 1 wherein 6,7-dehydro atropine is converted by reduction into atropine having the following formula: 5. The method of claim 4 wherein said reduction of 6,7-dehydro atropine occurs by diimide reduction wherein hydrazine is oxidized to a diimide in situ. 6. The method of claim 1 wherein R is a benzyl group, said first tetrachloro-bicyclic compound comprises benzyl 2,2,4,4-tetrachloro-3-oxo-8-azabicyclo[3.2.1]oct-6-ene-8-carboxylate and said second bicyclic compound comprises benzyl 3-oxo-8-azabicyclo[3.2.1]oct-6-ene-8-carboxylate. 7. The method of claim 1 wherein in step (b), said reaction of said pyrrole with pentachloroacetone takes place in the presence of N-methylmorpholine. 8. The method of claim 1 wherein in step (b), pentachloroacetone is provided in situ from hexachloroacetone. 9. A method for preparing scopolamine comprising: (a) providing a protected pyrrole having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (b) reacting the protected pyrrole with pentachloroacetone, wherein said pentachloroacetone is provided in situ from hexachloroacetone and forming a first tetrachloro-bicyclic compound having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (c) carrying out a reductive dechlorination of said first tetrachloro-bicyclic compound and forming a second bicyclic compound having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (d) carrying out a reductive methylation of the second bicyclic compound formed in step (c) and forming or 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3-ol having the following formula: (e) converting 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3-ol into 6,7-dehydro tropene tosylate having the following formula: wherein − OTs is reference to − OSO 2 —Ar—CH 3 ; and (f) converting 6,7-dehydro tropene tosylate into 6,7-dehydro atropine having the following formula:  and (g) converting 6,7-dehydro atropine by oxidation into scopolamine having the following formula: 10. The method of claim 9 wherein said oxidation of 6,7-dehydro atropine occurs in the presence of manganese sulfate, hydrogen peroxide and sodium bicarbonate. 11. A method for preparing atropine comprising: (a) providing a protected pyrrole having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (b) reacting the protected pyrrole with pentachloroacetone, wherein said pentachloroacetone is provided in situ from hexachloroacetone and forming a first tetrachloro-bicyclic compound having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (c) carrying out a reductive dechlorination of said first tetrachloro-bicyclic compound and forming a second bicyclic compound having the following formula: wherein R may be an alkyl group, phenyl group, or benzyl group; (d) carrying out a reductive methylation of the second bicyclic compound formed in step (c) and forming or 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3-ol having the following formula: (e) converting 8-methyl-8-azabicyclo[3.2.1]oct-6-en-3-ol into 6,7-dehydro tropene tosylate having the following formula: wherein − OTs is reference to − OSO 2 —Ar—CH 3 ; and (f) converting 6,7-dehydro tropene tosylate into 6,7-dehydro atropine having the following formula:  and converting 6,7-dehydro atropine by reduction into atropine having the following formula: 12. The method of claim 11 wherein said reduction of 6,7-dehydro atropine occurs by diimide reduction wherein hydrazine is oxidized to diimid

Assignees

Inventors

Classifications

  • C07D451/10Primary

    acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11739084B2 cover?
A synthetic route to scopolamine and/or atropine. In such context, the present invention identifies a method for preparing 6,7-dehydro atropine, which can be converted into either scopolamine and/or atropine, along with a method for converting a protected pyrrole into a tetrachlorobicylic compound, such as benzyl 3-oxo-8-azabicyclo[3.2.1]oct-6-ene-8-carboxylate.
Who is the assignee on this patent?
Southwest Res Inst
What technology area does this patent fall under?
Primary CPC classification C07D451/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).